Literature DB >> 17971657

Simultaneous hybrid coronary revascularization using totally endoscopic left internal mammary artery bypass grafting and placement of rapamycin eluting stents in the same interventional session. The COMBINATION pilot study.

Johannes Bonatti1, Thomas Schachner, Nikolaos Bonaros, Patrycja Jonetzko, Armin Ohlinger, Elisabeth Ruetzler, Christian Kolbitsch, Gudrun Feuchtner, Guenther Laufer, Otmar Pachinger, Guy Friedrich.   

Abstract

OBJECTIVES: Hybrid coronary revascularization procedures apply minimally invasive coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for treatment of multivessel coronary artery disease. For logistic reasons simultaneous procedures would be desirable. In a pilot study the feasibility of simultaneous robotic totally endoscopic CABG and PCI using drug eluting stents was assessed. PATIENTS AND METHODS: Five patients were scheduled to undergo simultaneous combined coronary intervention. A left internal mammary artery bypass graft was placed to the left anterior descending artery (LAD) in a completely endoscopic fashion using the daVinci telemanipulation system. PCI was carried out in the surgical operating room with the GE OEC9800 mobile coronary angiography C-arm. Rapamycin coated Cypher stents were placed into stenotic non-LAD targets.
RESULTS: The procedure was feasible in 4 patients, one patient was converted to a double CABG operation. There were no significant postoperative clinical complications and patients were discharged from intensive care unit and the hospital after 19 (18-61) hours and 6 (5-7) days respectively. At 6 months postoperatively all patients are free from angina.
CONCLUSION: We conclude that simultaneous robotic totally endoscopic left internal mammary artery to LAD placement and PCI to non-LAD targets using drug eluting stents is feasible in one session. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971657     DOI: 10.1159/000110486

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  8 in total

1.  Robotic cardiac surgery by 2031.

Authors:  W Randolph Chitwood
Journal:  Tex Heart Inst J       Date:  2011

2.  Robotic coronary artery bypass grafting.

Authors:  Thierry A Folliguet; Alain Dibie; François Philippe; Fabrice Larrazet; Michel S Slama; François Laborde
Journal:  J Robot Surg       Date:  2010-10-09

Review 3.  Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease.

Authors:  Ralf E Harskamp; Zhe Zheng; John H Alexander; Judson B Williams; Ying Xian; Michael E Halkos; J Matthew Brennan; Robbert J de Winter; Peter K Smith; Renato D Lopes
Journal:  Ann Thorac Surg       Date:  2013-12       Impact factor: 4.330

Review 4.  Combining PCI and CABG: the role of hybrid revascularization.

Authors:  Kelly D Green; Donald R Lynch; Tyffany P Chen; David Zhao
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

5.  Robotically-assisted coronary artery bypass grafting.

Authors:  Thierry A Folliguet; Alain Dibie; François Philippe; Fabrice Larrazet; Michel S Slama; François Laborde
Journal:  Cardiol Res Pract       Date:  2010-03-18       Impact factor: 1.866

6.  Combined PCI and minimally invasive heart valve surgery for high-risk patients.

Authors:  Ramanan Umakanthan; Marzia Leacche; Michael R Petracek; David X Zhao; John G Byrne
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

7.  Hybrid coronary revascularization as a safe, feasible, and viable alternative to conventional coronary artery bypass grafting: what is the current evidence?

Authors:  Arjan J F P Verhaegh; Ryan E Accord; Leen van Garsse; Jos G Maessen
Journal:  Minim Invasive Surg       Date:  2013-04-03

8.  The evolution of laparoscopy and the revolution in surgery in the decade of the 1990s.

Authors:  William E Kelley
Journal:  JSLS       Date:  2008 Oct-Dec       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.